FindTrial
Sign In

A Clinical Trial to study the duration of effects between two drugs Ropivacaine Heavy and Bupivacaine Heavy in pregnant women

A COMPARATIVE EFFICACY BETWEEN 0.5 percent ROPIVACAINE HEAVY VS 0.5 percent BUPIVACAINE HEAVY FOR INTRATHECAL ANAESTHESIA IN CEASAREAN SECTION - A PROSPECTIVE, DOUBLE-BLIND RANDOMISED CONTROLLED TRIAL - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/078986
Enrollment
132
Registered
2025-01-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Ropivacaine heavy: Lower back of patients will be painted with betadine and surgical spirit. Sterile drapes will be placed. A 25 gauge Quincke’s needle will be inserted at the level of

Sponsors

Heritage Institute Of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnancy (over 37 weeks and less than 42weeks)

Exclusion criteria

Exclusion criteria: Patients refusal Infection at the site of injection Coagulopathy or any other bleeding diathesis Increased intracranial pressure Known case of any hypersensitive reactions to local anaesthetics

Design outcomes

Primary

MeasureTime frame
To compare the duration of analgesia between Ropivacaine and Bupivacaine in intrathecal anaesthesiaTimepoint: Every 15 minutes during intra operative—

Secondary

MeasureTime frame
To compare the onset & duration of sensory & motor block , hemodynamic changes & side effects in both the groupsTimepoint: Every 15 minutes till 3 hours & then every 30 mins till 12 hours—

Countries

India

Contacts

Public ContactDr Pragya Shukla

Heritage Institute of Medical Sciences

pushkarranjanbhu@gmail.com9415986684

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026